Scorpion venoms as a potential source of novel cancer therapeutic compounds

Scorpions and their venoms have been used in traditional medicine for thousands of years in China, India and Africa. The scorpion venom is a highly complex mixture of salts, nucleotides, biogenic amines, enzymes, mucoproteins, as well as peptides and proteins (e.g. neurotoxins). One of the recently observed biological properties of animal venoms and toxins is that they possess anticancer potential. An increasing number of studies have shown that scorpion venoms and toxins can decrease cancer growth, induce apoptosis and inhibit cancer progression and metastasis in vitro and in vivo. Several active molecules with anticancer activities, ranging from inhibition of proliferation and cell cycle arrest to induction of apoptosis and decreasing cell migration and invasion, have been isolated from scorpion venoms. These observations have shed light on the application of scorpion venoms and toxins as potential novel cancer therapeutics. This mini-review focuses on the anticancer potential of scorpion venoms and toxins and the possible mechanisms for their antitumor activities.

[1]  M. Szatkowski,et al.  Contribution of functional voltage‐gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: II. Secretory membrane activity , 2003, Journal of cellular physiology.

[2]  M. Gonda,et al.  Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  F. Peng,et al.  Cloning and characterization of a cDNA sequence encoding the precursor of a chlorotoxin-like peptide from the Chinese scorpion Buthus martensii Karsch. , 2000, Toxicon : official journal of the International Society on Toxinology.

[4]  M. Khazaeli,et al.  Use of chlorotoxin for targeting of primary brain tumors. , 1998, Cancer research.

[5]  P. Gopalakrishnakone,et al.  Isolation and characterization of a hyaluronidase from the venom of Chinese red scorpion Buthus martensi. , 2008, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[6]  Yong-hua Ji,et al.  Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro , 2005, Journal of Neuro-Oncology.

[7]  P. Gopalakrishnakone,et al.  Purification and N-terminal sequence of a serine proteinase-like protein (BMK-CBP) from the venom of the Chinese scorpion (Buthus martensii Karsch). , 2008, Toxicon : official journal of the International Society on Toxinology.

[8]  Xiaoping Zhou,et al.  Purification and N-terminal partial sequence of anti-epilepsy peptide from venom of the scorpion Buthus martensii Karsch. , 1989, The Biochemical journal.

[9]  H. Sontheimer,et al.  Human astrocytoma cells express a unique chloride current , 1995, Neuroreport.

[10]  G. Strichartz,et al.  Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. , 1993, The American journal of physiology.

[11]  O. Crociani,et al.  Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. , 2009, Current medicinal chemistry.

[12]  L. Bubendorf,et al.  KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer , 2007, Oncogene.

[13]  Genomic cloning, characterization and statistical analysis of an antitumor-analgesic peptide from Chinese scorpion Buthus martensii Karsch. , 2010, Toxicon : official journal of the International Society on Toxinology.

[14]  Xueting Cai,et al.  Expression and purification of an antitumor‐analgesic peptide from the venom of Mesobuthus martensii Karsch by small ubiquitin–related modifier fusion in Escherichia coli , 2010, Biotechnology progress.

[15]  H. Bawaskar,et al.  Scorpion sting: update. , 2012, The Journal of the Association of Physicians of India.

[16]  L. Soroceanu,et al.  Modulation of Glioma Cell Migration and Invasion Using Cl− and K+ Ion Channel Blockers , 1999, The Journal of Neuroscience.

[17]  Xue-liang Chen,et al.  Upregulation of PTEN involved in scorpion venom-induced apoptosis in a lymphoma cell line , 2009, Leukemia & lymphoma.

[18]  H. Sontheimer,et al.  Chlorotoxin, a scorpion‐derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin , 2002, Glia.

[19]  A. Saha,et al.  Apoptosis induction in human leukemic cells by a novel protein Bengalin, isolated from Indian black scorpion venom: through mitochondrial pathway and inhibition of heat shock proteins. , 2010, Chemico-biological interactions.

[20]  A. Saha,et al.  Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562. , 2007, Leukemia research.

[21]  R. Coombes,et al.  Voltage-Gated Sodium Channel Expression and Potentiation of Human Breast Cancer Metastasis , 2005, Clinical Cancer Research.

[22]  T. E. Heinen,et al.  Arthropod venoms and cancer. , 2011, Toxicon : official journal of the International Society on Toxinology.

[23]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[24]  Jan Tytgat,et al.  An overview of toxins and genes from the venom of the Asian scorpion Buthus martensi Karsch. , 2002, Toxicon : official journal of the International Society on Toxinology.

[25]  Harald Sontheimer,et al.  Chlorotoxin Inhibits Glioma Cell Invasion via Matrix Metalloproteinase-2* , 2003, The Journal of Biological Chemistry.

[26]  Rongqin Huang,et al.  Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration. , 2011, Biomaterials.

[27]  Zhao-xia Wang,et al.  Anti-proliferation Effect of Polypeptide Extracted from Scorpion Venom on Human Prostate Cancer Cells in vitro , 2009, Journal of clinical medicine research.

[28]  Li Wenxin,et al.  Cloning and characterization of a novel calcium channel toxin-like gene BmCa1 from Chinese scorpion Mesobuthus martensii Karsch , 2006, Peptides.

[29]  J. Chippaux,et al.  Epidemiology of scorpionism: a global appraisal. , 2008, Acta tropica.

[30]  Andrea Becchetti,et al.  Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. , 2011, American journal of physiology. Cell physiology.

[31]  A. Gomes,et al.  Anticancer potential of animal venoms and toxins. , 2010, Indian journal of experimental biology.

[32]  M. Roudbaraki,et al.  Cell-cycle-dependent expression of the large Ca2+-activated K+ channels in breast cancer cells. , 2004, Biochemical and biophysical research communications.

[33]  Shakir Ali,et al.  Scorpion venom (Odontobuthus doriae) induces apoptosis by depolarization of mitochondria and reduces S-phase population in human breast cancer cells (MCF-7). , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[34]  Yuejun Fu,et al.  Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs , 2012, Journal of Neuro-Oncology.

[35]  C. Sevcik,et al.  Apoptogenic peptides from Tityus discrepans scorpion venom acting against the SKBR3 breast cancer cell line. , 2010, Toxicon : official journal of the International Society on Toxinology.

[36]  Shakir Ali,et al.  Scorpion (Odontobuthus doriae) venom induces apoptosis and inhibits DNA synthesis in human neuroblastoma cells , 2011, Molecular and Cellular Biochemistry.

[37]  A. Schwab,et al.  K+ Channel-Dependent Migration of Fibroblasts and Human Melanoma Cells , 1999, Cellular Physiology and Biochemistry.

[38]  Shakir Ali,et al.  Scorpion (Androctonus crassicauda) venom limits growth of transformed cells (SH-SY5Y and MCF-7) by cytotoxicity and cell cycle arrest. , 2011, Experimental and molecular pathology.

[39]  Fang Liu,et al.  Anti-HIV-1 Activity of a New Scorpion Venom Peptide Derivative Kn2-7 , 2012, PloS one.

[40]  M. Djamgoz,et al.  Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer. , 2009, European journal of pharmacology.

[41]  So Yeong Lee,et al.  Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. , 2011, European journal of pharmacology.

[42]  Nina M. Muñoz,et al.  Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. , 2007, Cancer research.

[43]  N. Prevarskaya,et al.  Ion channels and the hallmarks of cancer. , 2010, Trends in molecular medicine.

[44]  Guojun Zhang,et al.  Scorpion venom component III inhibits cell proliferation by modulating NF-κB activation in human leukemia cells. , 2012, Experimental and Therapeutic Medicine.

[45]  H. Sowter,et al.  Eag and HERG potassium channels as novel therapeutic targets in cancer , 2010, World journal of surgical oncology.

[46]  Yingliang Wu,et al.  Mucroporin-M1 Inhibits Hepatitis B Virus Replication by Activating the Mitogen-activated Protein Kinase (MAPK) Pathway and Down-regulating HNF4α in Vitro and in Vivo* , 2012, The Journal of Biological Chemistry.

[47]  B. Chai,et al.  Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas , 2007, Neuroscience Letters.

[48]  Antonio Felipe,et al.  Potassium channels: new targets in cancer therapy. , 2006, Cancer detection and prevention.

[49]  R. Berridge,et al.  Contribution of functional voltage‐gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. lateral motility , 2003, Journal of cellular physiology.

[50]  G. King,et al.  Venoms as a platform for human drugs: translating toxins into therapeutics , 2011, Expert opinion on biological therapy.

[51]  Yeong Shik Kim,et al.  Cytotoxicity and L-amino acid oxidase activity of crude insect drugs , 2000, Archives of pharmacal research.

[52]  H. Sontheimer,et al.  Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells. , 1996, The American journal of physiology.

[53]  K. Becker,et al.  Targeted therapies in cancer - challenges and chances offered by newly developed techniques for protein analysis in clinical tissues , 2010, Journal of Cancer.

[54]  Hui Liu,et al.  BmKCT toxin inhibits glioma proliferation and tumor metastasis. , 2010, Cancer letters.

[55]  B. Kramer,et al.  Trends in biomarker research for cancer detection. , 2001, The Lancet. Oncology.

[56]  A. Ménez,et al.  'Venomics' or : The venomous systems genome project. , 2006, Toxicon : official journal of the International Society on Toxinology.

[57]  Chunfu Wu,et al.  Purification and characterization of an analgesic peptide from Buthus martensii Karsch. , 2007, Biomedical chromatography : BMC.

[58]  C. Foster,et al.  A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo , 2005, Prostate Cancer and Prostatic Diseases.

[59]  A. Arcangeli,et al.  American Journal of Physiology-Cell Physiology theme: ion channels and transporters in cancer. , 2011, American journal of physiology. Cell physiology.

[60]  Shuang-quan Zhang,et al.  Analgesic‐antitumor peptide inhibits proliferation and migration of SHG‐44 human malignant glioma cells , 2011, Journal of cellular biochemistry.

[61]  A. King,et al.  Principles of cancer treatment by surgery , 2003 .

[62]  M. Deutscher,et al.  Guide to Protein Purification , 2009 .

[63]  Chun-Fu Wu,et al.  Expression of an antitumor-analgesic peptide from the venom of Chinese scorpion Buthus martensii karsch in Escherichia coli. , 2003, Protein expression and purification.

[64]  Chunfu Wu,et al.  ISOLATION, PURIFICATION, AND N-TERMINAL PARTIAL SEQUENCE OF AN ANTITUMOR PEPTIDE FROM THE VENOM OF THE CHINESE SCORPION BUTHUS MARTENSII KARSCH , 2002, Preparative biochemistry & biotechnology.